Paper Discussion: Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Disease

In the video below, Steve Hill from Lifespan.io and I talk about findings from a recent paper (https://content.iospress.com/articles/journal-of-alzheimers-disease/jad200306) that supports a role for the gut microbiome on Alxheimer’s disease. Check it out!

Michael Lustgarten

Ph.D, Physiology, University of Texas Health Science Center at San Antonio, 2009 B.S., Biochemistry, Queens College, 2003 B.A, English Textual Studies, 1994, Syracuse University

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Next Post

My Road to Maximize Lifespan - Monitor Biomarkers To Reverse Aging | Dr. Michael Lustgarten | Parts I - VII

Tue Dec 1 , 2020
Here’s an interview that I did with Richard at Modern Healthspan, one of the best interviewers in aging! Part I: Monitoring Biomarkers to Reverse Aging: Part II, Diet, CR & Fasting: Part III: Exercise, Protein Part IV: Optimize Nutrients Through Diet Part V: Inhibit CD38 to Optimize NAD Part VI: […]
%d bloggers like this: